Drugs / Racemic formoterol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00685529 Comparator | Apr → Oct 2005 | chronic obstructive pulmonary disease | Sumitomo Pharma America, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Racemic formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00685529 ↗ |
| Route | Inhaled | “medication via nebulization or DPI” NCT00685529 ↗ |